Dr. Gregg S. Bolotin, MD

Dr. Bolotin practices at Sharp Chula Vista Medical Center in Chula Vista, California, part of Sharp HealthCare.

Dr. Bolotin's NPI, 1366451601, was assigned on August 5, 2006. Dr. Bolotin graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science in 1989. Dr. Bolotin holds California license G70468.

Dr. Bolotin's primary practice is Sharp Chula Vista Medical Center, at 751 Medical Center Court, Chula Vista, CA 91911 in San Diego County. The practice phone is (619) 502-5800.

Dr. Bolotin's primary practice is Sharp Chula Vista Medical Center in Chula Vista, California, part of Sharp HealthCare. The medical group on file is Vituity. Dmand AI also links Dr. Bolotin to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bolotin practices. Vendor and product names are available with a free account.

Emergency medicine is Dr. Bolotin's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dr. Bolotin is board certified in emergency medicine by the American Board of Emergency Medicine. Dmand AI has Dr. Bolotin's licenses on file in 2 states: California and Illinois.

CMS data shows 727 Medicare services from Dr. Bolotin across 7 procedure codes in 2024, for 312 Medicare patients. Medicare paid $56,321 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 312 Medicare patients who saw Dr. Bolotin in 2024. The largest group is 65 to 74, with 100 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 56% are also on Medicaid. Their average risk score is 2.61, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bolotin's median patient age at 50, with 60% women.

In 2024, Dr. Bolotin wrote 547 Medicare Part D claims for 281 patients. 96% of them were for generic drugs. CMS names the drug for 389 of them, across 17 drugs with 11 or more claims each, at $2,440 in total drug cost. In 2023, CMS named 285 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Bolotin for performance year 2024, reported as part of a group. Dr. Bolotin accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 30 general payments to Dr. Bolotin from 9 drug and device companies from 2016 to 2023. Food and beverage make up the largest share, 99% of the total. Boston Scientific Corporation paid the most, $387.

Dr. Bolotin graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science in 1989.

Dr. Bolotin is in network with 2 carriers, including CMS Medicare and RI State Medicaid. Medicaid plans come from the most carriers, 1. Check the plan with the practice before a visit.